GLOBAL DUPUYTRENS DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Dupuytren’s Disease Market, By Disease Type (Type I, Type II, and Type III), By Type (Diagnosis (Physical Examination, and X-ray) and Treatment (Surgery, Radiation Therapy, Needle Aponeurotomy, Steroid Shot, Enzyme Injection, Occupational Therapy, and Others), By End User (Hospitals, Clinics, Academic & Research Institute, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Recent Developments

New product launches

On August 3, 2023, 180 Life Sciences Corp., a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, announced that it has submitted a request to the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) for a follow up scientific advice meeting where the company will seek guidance on a plan to obtain Conditional Marketing Authorization (CMA) for the use of adalimumab in the treatment of early stage Dupuytren’s disease.